April 24, 2014

As part of the launch of DSN’s new microsite, DrugStoreNews.com/Pain-Management, DSN had the opportunity to speak with Carmen Catizone, executive director of the National Association of Boards of Pharmacy, regarding a new initiative that the association is spearheading to address the current patient access problem when it comes to pain management pharmaceuticals.

January 23, 2014

In a recent report, 59News explored how DEA regulations on pain medications can limit a pharmacy's supply, preventing patients from obtaining their medications.

January 8, 2014

News stories about doctor shopping and prescription pad pilfering in pursuit of a pain-pill induced high have become commonplace, prompting many legislators and regulators to consider further restrictions on pain medicines like hydrocodone compounds. But there may be a story that’s not being told — that the patients who suffer from chronic pain and need that hydrocodone to reclaim their lives are being stigmatized. The prevalence of pain pill abuse has left in its wake as many as 116 million legitimate pain sufferers who are finding it more difficult to access their therapies.

January 2, 2014

One reason pain patient advocates are so passionate about what they do is because they are pain patients themselves — they know the stigma associated with chronic pain; they know how difficult it can be to access appropriate pain therapy sometimes. That’s the story of Gina Libby, volunteer pain patient advocate who has lived with chronic pain for more than 20 years.

February 1, 2017

Product intended to work well for diabetics by soothing and protecting after puncture, and last for approximately three months.

January 25, 2017
The FDA’s approval of the new formulation comes a little more than a year after it approved the nasal spray in a 4-mg formulation. 


January 10, 2017

Egalet said Arymo ER is the first drug approved using its proprietary Guardian Technology, which works to deter abuse and prevent the tablets from being manipulated for abuse or misuse. 

December 7, 2016

NCPA addressed several areas where independent community pharmacies and the patients they serve could be adversely affected by the pharmacy “lock-in” provision in the opioid abuse legislation.

September 29, 2016

Prime said there were 20.5 million opioid claims in the time period between Jan. 1, 2014 and March 31, 2016. 

September 6, 2016

There's a new reusable applicator that freezes injection sites to reduce pain and discomfort, and it's targeted specifically at people with diabetes. 

August 31, 2016

Among the changes, the FDA is requiring boxed warnings for nearly 400 products, as well as patient-focused Medication Guides for prescription opioids and benzodiazepines.

August 17, 2016
The death rate from opioid overdose in the United States had increased 200% since the year 2000, with deaths impacting people between ages 25 and 44 years, particularly in southern states. 
August 1, 2016

Through this partnership, CVS Pharmacy patients purchasing Narcan Nasal Spray without insurance will receive a $35 discount coupon to purchase the medication.

July 18, 2016

Cefaly I has a tremendous success record. In clinical trials 81% of compliant patients showed a significant reduction in migraine attacks and up to a 75% reduction in consumption of migraine medications.

June 27, 2016

Pharmasave announced that its pharmacists have been trained to be leaders in providing medication therapy management programs.

June 6, 2016

Value-based care is driving a number of positive trends within the retail pharmacy sector.

June 3, 2016

WellCare Kentucky — a subsidiary of WellCare Health Plans — is making 1,000 twist-on naloxone nasal atomizers available for free, and pharmacists will provide them to Medicaid recipients and patients who don’t have insurance without a prescription.

May 25, 2016

CVS Health’s efforts to dispense opioid overdose reversal drug naloxone without a prescription has already come to 23 states and the company has announced plans to expand to seven more over the course of the summer.

May 24, 2016

Forbes recently reported on CVS Health’s efforts to curb opioid abuse, highlighting its push to provide naloxone — the drug that reverses an opioid overdose — without a prescription through its pharmacies in 20 states by the end of the year, with plans to do so in all 50 states. The magazine spoke to CVS Health VP professional services Tom Davis about the efforts, and Davis notes that “when dispensing naloxone, our pharmacists counsel patients and caregivers on a number of important points including: identifying an overdose, the importance of calling 911, giving rescue breaths, administering naloxone and remaining with the patient until help arrives.” (Forbes)

May 24, 2016

The New York Times reports that the number of opioid prescriptions in the United States is falling for the first time since OxyContin hit the market in 1996. (New York Times)

May 9, 2016

A record number of Americans showed up last weekend to turn in their unused prescription drugs, according to the Drug Enforcement Agency. 

April 20, 2016

The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 seeks to increase collaboration between health and enforcement bodies on drug abuse solutions.

April 18, 2016

Consumers looking for the most technologically advanced home pregnancy test available now have a new option from a leading brand.

April 15, 2016

Retailers and technology vendors convened at the fifth annual Health, Wellness and Technology Roundtable to discuss what they see in the current technology today, what they expect in 2016 and some of the unmet technology needs.